Cover Image
市場調查報告書

美國的自體免疫疾病診斷市場機會:2010年∼2020年

United States Autoimmune Disorders Diagnostics Market Opportunities, 2020

出版商 Pharmaion 商品編碼 346827
出版日期 內容資訊 英文 89 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的自體免疫疾病診斷市場機會:2010年∼2020年 United States Autoimmune Disorders Diagnostics Market Opportunities, 2020
出版日期: 2015年12月11日 內容資訊: 英文 89 Pages
簡介

由於醫療費的增加,及自體免疫疾病診斷的需求迅速高漲、進行中的各種技術的進步、創新的診斷程序登場,美國的自體免疫疾病診斷市場預計今後也將擴大。

本報告提供美國的自體免疫疾病診斷市場相關調查分析、市場規模和各市場區隔的佔有率、市場動態、主要趨勢、競爭情形、收益預測、主要企業等系統性資訊。

第1章 自體免疫疾病診斷概要

第2章 分析師的見解

第3章 調查手法

第4章 疾病的流行病學

第5章 全球自體免疫疾病診斷市場概要

第6章 美國的自體免疫疾病診斷市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各標的疾病
    • 各檢查
    • 各技術
    • 各地區

第7章 美國的抗核抗體檢驗市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各類型

第8章 市場動態

  • 推動因素
  • 課題

第9章 市場趨勢與發展

  • 生物標記的利用增加
  • 研究所的自動化
  • 實驗室晶片設備
  • 手機用診斷設備
  • 醫生和診斷研究所的聯合

第10章 政策和法規形勢

第11章 美國的經濟簡介

第12章 競爭情形

  • 競爭基準
  • 企業簡介
    • Bio-Rad Laboratories, Inc.
    • Roche Diagnostics Corporation
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthcare Diagnostics, Inc.
    • Biomeriux Clinical Diagnostics
    • Immco Diagnostics
    • Beckton Dickson
    • Alere Inc.
    • Inova Diagnostics, Inc.

第13章 策略性建議

圖表

目錄

Autoimmune disorders occur when a person's immune system attacks his/her own body; and for detecting these disorders and prescribing required treatments, various laboratory tests are performed. Increasing healthcare expenditure, rapidly rising demand for autoimmune disease diagnostics and various ongoing technological advancements leading to the advent of innovative diagnostic procedures are some of the major factors anticipated to drive the United States autoimmune disorders diagnostics market over the next five years. Furthermore, growing disease burden of various autoimmune disorders, especially Rheumatoid Arthritis, Type 1 Diabetes, Multiple Sclerosis, Systemic Lupus Erythematosus (SLE), Inflammatory Bowel Disease (IBD), Psoriasis and Autoimmune Thyroiditis, is expected to boost the US autoimmune disorders diagnostics market through 2020.

According to Pharmaion report, "United States Autoimmune Disorders Diagnostics Market Opportunities, 2020", the autoimmune disorders diagnostics market in the United States is anticipated to cross US$ 6 billion by 2020. On the basis of target disease, the market is broadly segmented into two categories, namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics. Among these two categories, systemic autoimmune disorders diagnostics segment dominated the United States autoimmune disorders diagnostics market in 2014. The segment is anticipated to continue its dominance through 2020 on account of increasing ongoing research activities that are focussed on developing tests and technologies that would precisely detect the abnormalities in the organ functioning and thus deliver faster diagnosis. The largest market share in the United States autoimmune disorders diagnostics market was captured by the South-East region, followed by the Midwest, North-East, West and South-West regions. Some of the major players operating in United States autoimmune disorders diagnostics market include Bio-Rad Laboratories, Inc., Roche Diagnostics Corporation, Abbott Laboratories, Danaher Corporation and Siemens Healthcare Diagnostics, Inc., among others. "United States Autoimmune Disorders Diagnostics Market Opportunities, 2020" discusses the following aspects related to United States autoimmune disorders diagnostics market:

  • United States Autoimmune Disorders Diagnostics Market Size, Share & Forecast
  • Segmental Analysis - By Target Disease, By Test, By Technology & By Region
  • Policy & Regulatory Landscape
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • To identify the on-going trends and anticipated growth in the next five years
  • To gain competitive knowledge of leading market players
  • To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer's specific needs

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with diagnostics device manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.

Table of Contents

1. Autoimmune Disorders Diagnostics Overview

2. Analyst View

3. Research Methodology

4. Disease Epidemiology

5. Global Autoimmune Disorders Diagnostics Market Overview

6. United States Autoimmune Disorders Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Target Disease (Systemic Autoimmune Disorders Diagnostics & Localized Autoimmune Disorders Diagnostics)
    • 6.2.2. By Test (Urinalysis, Comprehensive Metabolic Panel, C-reactive Protein, Erythrocyte Sedimentation Rate, Complete Blood Count, Anti-Nuclear Antibody Test & Others)
    • 6.2.3. By Technology (Enzyme Immunoassay, Multiplexed Immunoassays, Immunofluorescence & Others)
    • 6.2.4. By Region (South-West, West, North-East, Midwest, South-East)

7. United States Anti-Nuclear Antibody Test Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type {Others (Anti-centromere Antibodies, Histone Antibody & Nucleolar Antibody), Anti-dsDNA Test & Extractable Nuclear Antigen (ENA) Panel}

8. Market Dynamics

  • 8.1. Drivers
  • 8.2. Challenges

9. Market Trends & Developments

  • 9.1. Increasing Use of Biomarkers
  • 9.2. Lab automation
  • 9.3. Lab-on-Chip Devices
  • 9.4. Portable Diagnostics Equipment
  • 9.5. Partnership with Physician and Diagnostics Laboratories

10. Policy & Regulatory Landscape

11. United States Economic Profile

12. Competitive Landscape

  • 12.1. Competition Benchmarking (Market Attractiveness)
  • 12.2. Company Profiles
    • 12.2.1. Bio-Rad Laboratories, Inc.
    • 12.2.2. Roche Diagnostics Corporation
    • 12.2.3. Abbott Laboratories
    • 12.2.4. Danaher Corporation
    • 12.2.5. Siemens Healthcare Diagnostics, Inc.
    • 12.2.6. Biomeriux Clinical Diagnostics
    • 12.2.7. Immco Diagnostics
    • 12.2.8. Beckton Dickson
    • 12.2.9. Alere Inc.
    • 12.2.10. Inova Diagnostics, Inc.

13. Strategic Recommendations

List of Figures

  • Figure 1: United States Autoimmune Disorders Prevalence per 100,000 Population, 2013
  • Figure 2: United States Autoimmune Disorders Diagnostics Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 3: United States Autoimmune Disorders Diagnostics Market Share, By Target Disorder, By Value, 2010-2020F
  • Figure 4: United States Autoimmune Disorders Diagnostics Market, By Test, By Value, 2010-2020F
  • Figure 5: United States Autoimmune Disorders Diagnostics Market Share, By Technology, By Value, 2010-2020F
  • Figure 6: United States Autoimmune Disorders Diagnostics Market Share, By Region, By Value, 2014 & 2020F
  • Figure 7: United States Autoimmune Disorders Diagnostics Market Share, By Region, By Value, 2010-2020F
  • Figure 8: United States Anti-Nuclear Antibody Test Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 9: United States Anti-Nuclear Antibody Test Market Share, By Type, By Value, 2010-2020F
  • Figure 10: United States Autoimmune Disease Prevalence, 2013 (Million)

List of Tables

  • Table 1: United States Average Annual Cost of Diagnosis and Treatment of Autoimmune Disorders, 2014
  • Table 2: United States Occurrence of Autoimmune Disorders in Males and Females
  • Table 3: Partial List of Autoimmune Diseases
  • Table 4: Conditions Associated with Positive Antinuclear Antibody (ANA) Test
  • Table 5: United States Research Funding for Autoimmune Disorder, By Year, (USD Million)
  • Table 6: List of Partners of Accelerating Medicine Partnership
Back to Top